>3 (vs air)
1 mmHg ( 20 °C)
250 ppm MEHQ as inhibitor
n20/D 1.431 (lit.)
2.0-2.2 (20 °C, 100 g/L)
163 °C (lit.)
12-16 °C (lit.)
1.015 g/mL at 25 °C (lit.)
Looking for similar products? Visit Product Comparison Guide
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1A - STOT SE 3
6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
152.6 °F - closed cup
67 °C - closed cup
Enter Lot Number to search for Certificate of Analysis (COA).
Enter Lot Number to search for Certificate of Origin (COO).
RAFT (Reversible Addition Fragmentation chain Transfer) polymerization is a reversible deactivation radical polymerization (RDRP) and one of the more versatile methods for providing living characteristics to radical polymerization.
The manufacture of monomers for use in ophthalmic applications is driven by the need for higher purity, improved reliability of manufacturing supply, but ultimately by the need for the increased comfort, convenience, and safety of contact lens wearers. Daily wear contact lenses have the potential to fill this need for many customers; however, their widespread use is constrained by higher costs compared to weekly- or monthly-based lenses. New approaches that improve cost structure and result in higher quality raw materials are needed to help make contact lenses more affordable and accelerate growth of the contact lens market.
By altering the physicochemical properties, smart or intelligent drug delivery systems can be designed to deliver therapeutic molecules on-demand. Learn more about the application of stimuli-responsive materials in drug delivery.